Recall: D-238-2013

Class III - Minor Violations

Class IIIClassification

2013-03-19Initiated

TerminatedStatus

Dr. Reddy'S LaboratoriesFirm

Product

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

Reason

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Distribution

Nationwide and Puerto Rico.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.